Canakinumab Subcutaneous and Dexamethasone SodiumPhosphate
Determining the interaction of Canakinumab Subcutaneous and Dexamethasone SodiumPhosphate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dexamethasone (intraocular), Dexamethasone (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Dexamethasone Solution (Drops)
- Canakinumab Subcutaneous-Dexamethasone Tablets
- Canakinumab Subcutaneous-Dexamethasone, neomycin, and polymyxin B ophthalmic
- Canakinumab Subcutaneous-Dexasone injection
- Canakinumab Subcutaneous-Dexasone LA injection
- Canakinumab Subcutaneous-Dexbrompheniramine
- Dexamethasone SodiumPhosphate-Canasa
- Dexamethasone SodiumPhosphate-Canasa Pac rectal
- Dexamethasone SodiumPhosphate-Canasa rectal
- Dexamethasone SodiumPhosphate-Cancidas
- Dexamethasone SodiumPhosphate-Candesartan
- Dexamethasone SodiumPhosphate-Candesartan and Hydrochlorothiazide